Biphenyl urea derivatives as selective CYP1B1 inhibitors
(2016)
Journal Article
© 2016 The Royal Society of Chemistry. Highly selective CYP1B1 inhibitors have potential in the treatment of hormone-induced breast and prostate cancers. Mimicry of potent and selective CYP1B1 inhibitors, α-naphthoflavone and stilbenes, revealed that... Read More about Biphenyl urea derivatives as selective CYP1B1 inhibitors.